Industry

Pharmaceuticals

Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.

Total Companies
1 293
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Eli Lilly and Co
NYSE:LLY
Loading...
61% Overvalued
76 / 100
68 / 100
$1T
Dechra Pharmaceuticals PLC
LSE:DPH
Loading...
N/A
43 / 100
52 / 100
$592.8B
Johnson & Johnson
NYSE:JNJ
Loading...
17% Overvalued
63 / 100
55 / 100
$511.7B
Roche Holding AG
SIX:ROG
Loading...
26% Undervalued
64 / 100
60 / 100
$337.9B
AstraZeneca PLC
LSE:AZN
Loading...
7% Undervalued
60 / 100
50 / 100
$291.2B
Novartis AG
SIX:NOVN
Loading...
4% Undervalued
67 / 100
66 / 100
$271.4B
Merck & Co Inc
NYSE:MRK
Loading...
10% Undervalued
67 / 100
68 / 100
$270.2B
Novo Nordisk A/S
CSE:NOVO B
Loading...
17% Undervalued
75 / 100
70 / 100
$269.7B
Pfizer Inc
NYSE:PFE
Loading...
10% Undervalued
51 / 100
45 / 100
$142.4B
Sanofi SA
PAR:SAN
Loading...
48% Undervalued
57 / 100
45 / 100
$115.8B
Bristol-Myers Squibb Co
NYSE:BMY
Loading...
18% Undervalued
61 / 100
40 / 100
$113.3B
GlaxoSmithKline PLC
LSE:GSK
Loading...
6% Undervalued
64 / 100
48 / 100
$100B
Chugai Pharmaceutical Co Ltd
TSE:4519
Loading...
46% Overvalued
67 / 100
93 / 100
$87.8B
Merck KGaA
XETRA:MRK
Loading...
7% Undervalued
51 / 100
56 / 100
$65.7B
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Loading...
11% Overvalued
60 / 100
80 / 100
$61.4B
Ucb SA
XBRU:UCB
Loading...
2% Undervalued
57 / 100
72 / 100
$56.4B
Zoetis Inc
NYSE:ZTS
Loading...
2% Undervalued
72 / 100
65 / 100
$55.3B
A
Aspen Pharmacare Holdings Ltd
JSE:APN
Loading...
N/A
46 / 100
43 / 100
$52.7B
Takeda Pharmaceutical Co Ltd
TSE:4502
Loading...
Fairly Valued
45 / 100
36 / 100
$50.1B
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Loading...
25% Overvalued
60 / 100
96 / 100
$46B
Load More